TLDR:
- Belgian biotech company Ion Beam Applications SA’s joint venture PanTera raised €93 million in venture capital funding.
- The funding round was oversubscribed and led by global investor EQT.
Ion Beam Applications SA, a Belgian biotech company, announced that its joint venture PanTera has successfully raised €93 million in an oversubscribed first round of venture capital funding. The round was led by global investor EQT, highlighting the growing interest and investment in the biotech sector, particularly in the field of cancer research.
This substantial funding round will enable PanTera to further advance its research and development efforts in innovative cancer treatments. The strong support from investors demonstrates confidence in the company’s potential and the value of its work in the biotech industry.
Overall, the funding round signifies a significant milestone for Ion Beam Applications SA and its joint venture PanTera as they continue to make strides in the field of cancer research and biotechnology.
